TMCnet News
Diagnos Updates Its Board [Professional Services Close - Up](Professional Services Close - Up Via Acquire Media NewsEdge) Diagnos announced the appointment of Lloyd M. Segal and Michael Singer as Directors of the Corp. following the resignations of Rich Baxter and Bruno Maruzzo. According to a release from the Company, the Board wishes to thank Baxter and Maruzzo for their contribution to DIAGNOS. Segal is Managing Partner at Persistence Capital Partners ("PCP"), Canada's only private equity fund exclusively focused on high-growth opportunities in Canadian healthcare. Segal is responsible for all aspects of PCP's investments from sourcing, evaluating and executing on investment opportunities, to managing existing investments. Segal has previously served as a director of several public and private corporations in the U.S. and Canada. Singer is a Pharmaceutical industry Chief Financial Officer and consultant with senior level experience in both public and private life science and innovative technology companies. Prior to joining DIAGNOS, Singer served as Chairman of the board of Directors of Warnex Inc. On July 8, Warnex was amalgamated with a wholly-owned subsidiary of DIAGNOS. Diagnos is a publicly traded Canadian corporation, with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. More information and complete details: www.diagnos.com www.sedar.com ((Comments on this story may be sent to [email protected])) (c) 2014 ProQuest Information and Learning Company; All Rights Reserved. |